Literature DB >> 19666619

Plugging the holes in hepatitis C virus antiviral therapy.

Stephen D C Griffin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19666619      PMCID： PMC2722315          DOI： 10.1073/pnas.0906760106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

1.  Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.

Authors:  Natalia A Ilyushina; Nicolai V Bovin; Robert G Webster; Elena A Govorkova
Journal:  Antiviral Res       Date:  2006-02-21       Impact factor: 5.970

2.  Determination of pore-lining residues in the hepatitis C virus p7 protein.

Authors:  Chee Foong Chew; Ranjit Vijayan; Jason Chang; Nicole Zitzmann; Philip C Biggin
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

3.  Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI).

Authors:  Marianne Maynard; Pierre Pradat; François Bailly; Frédéric Rozier; Chantal Nemoz; Si Nafa Si Ahmed; Patrice Adeleine; Christian Trépo
Journal:  J Hepatol       Date:  2005-12-20       Impact factor: 25.083

4.  Amantadine's viral kinetics in chronic hepatitis C infection.

Authors:  Juliana Chan; Kenneth O'Riordan; Thelma E Wiley
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

5.  The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy.

Authors:  Philipp Luik; Chee Chew; Jussi Aittoniemi; Jason Chang; Paul Wentworth; Raymond A Dwek; Philip C Biggin; Catherine Vénien-Bryan; Nicole Zitzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-09       Impact factor: 11.205

6.  Reverse genetic analysis of a putative, influenza virus M2 HXXXW-like motif in the p7 protein of hepatitis C virus.

Authors:  Z Meshkat; M Audsley; C Beyer; E J Gowans; G Haqshenas
Journal:  J Viral Hepat       Date:  2008-10-17       Impact factor: 3.728

7.  Structure and mechanism of the M2 proton channel of influenza A virus.

Authors:  Jason R Schnell; James J Chou
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

8.  Structural basis for the function and inhibition of an influenza virus proton channel.

Authors:  Amanda L Stouffer; Rudresh Acharya; David Salom; Anna S Levine; Luigi Di Costanzo; Cinque S Soto; Valentina Tereshko; Vikas Nanda; Steven Stayrook; William F DeGrado
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

9.  Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.

Authors:  Stephen Griffin; Corine Stgelais; Ania M Owsianka; Arvind H Patel; David Rowlands; Mark Harris
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

10.  Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions.

Authors:  Eike Steinmann; Francois Penin; Stephanie Kallis; Arvind H Patel; Ralf Bartenschlager; Thomas Pietschmann
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823
View more
  9 in total

1.  High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors.

Authors:  Laura F Wetherill; Kristopher K Holmes; Mark Verow; Marietta Müller; Gareth Howell; Mark Harris; Colin Fishwick; Nicola Stonehouse; Richard Foster; G Eric Blair; Stephen Griffin; Andrew Macdonald
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

2.  A Global Genomic Characterization of Nairoviruses Identifies Nine Discrete Genogroups with Distinctive Structural Characteristics and Host-Vector Associations.

Authors:  Peter J Walker; Steven G Widen; Thomas G Wood; Hilda Guzman; Robert B Tesh; Nikolaos Vasilakis
Journal:  Am J Trop Med Hyg       Date:  2016-02-22       Impact factor: 2.345

3.  Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis.

Authors:  Carlos Castaño-Rodriguez; Jose M Honrubia; Javier Gutiérrez-Álvarez; Marta L DeDiego; Jose L Nieto-Torres; Jose M Jimenez-Guardeño; Jose A Regla-Nava; Raul Fernandez-Delgado; Carmina Verdia-Báguena; Maria Queralt-Martín; Grazyna Kochan; Stanley Perlman; Vicente M Aguilella; Isabel Sola; Luis Enjuanes
Journal:  mBio       Date:  2018-05-22       Impact factor: 7.867

Review 4.  Mechanism of function of viral channel proteins and implications for drug development.

Authors:  Wolfgang B Fischer; Yi-Ting Wang; Christina Schindler; Chin-Pei Chen
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 5.  Viroporins: structure and biological functions.

Authors:  José Luis Nieva; Vanesa Madan; Luis Carrasco
Journal:  Nat Rev Microbiol       Date:  2012-07-02       Impact factor: 60.633

Review 6.  Functions of Coronavirus Accessory Proteins: Overview of the State of the Art.

Authors:  Puxian Fang; Liurong Fang; Huichang Zhang; Sijin Xia; Shaobo Xiao
Journal:  Viruses       Date:  2021-06-13       Impact factor: 5.048

7.  An assay suitable for high throughput screening of anti-influenza drugs.

Authors:  Lili Mao; Jun Wang; William F DeGrado; Masayori Inouye
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

8.  Computational modeling of the p7 monomer from HCV and its interaction with small molecule drugs.

Authors:  Yi-Ting Wang; Hao-Jen Hsu; Wolfgang B Fischer
Journal:  Springerplus       Date:  2013-07-18

9.  Bluetongue virus nonstructural protein NS3/NS3a is not essential for virus replication.

Authors:  René G P van Gennip; Sandra G P van de Water; Piet A van Rijn
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.